Gene · 3482
Papers4,462
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 4,462
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| BRAF Mutations in Melanoma: Biological Aspects, Therapeutic Implications, and Circulating Biomarkers. | Cancers (Basel) | 2023 | 37627054 | PubTator, text mining | PubMed |
| Novel epigenetic molecular therapies for imprinting disorders. | Mol Psychiatry | 2023 | 37626134 | PubTator, text mining | PubMed |
| Sex- and APOE-specific genetic risk factors for late-onset Alzheimer's disease: Evidence from gene-gene interaction of longevity-related loci. | Aging Cell | 2023 | 37621137 | PubTator, text mining | PubMed |
| A genome-wide atlas of human cell morphology. | bioRxiv | 2023 | 37609130 | PubTator, text mining | PubMed |
| Non-glycosylated IGF2 prohormones are more mitogenic than native IGF2. | Commun Biol | 2023 | 37598269 | PubTator, text mining | PubMed |
| Role of the DEAD-box RNA helicase DDX5 (p68) in cancer DNA repair, immune suppression, cancer metabolic control, virus infection promotion, and human microbiome (microbiota) negative influence. | J Exp Clin Cancer Res | 2023 | 37596619 | PubTator, text mining | PubMed |
| Opportunities and challenges of protein-based targeted protein degradation. | Chem Sci | 2023 | 37592990 | PubTator, text mining | PubMed |
| Targeted Lysosomal Degradation of Secreted and Cell Surface Proteins through the LRP-1 Pathway. | J Am Chem Soc | 2023 | 37590164 | PubTator, text mining | PubMed |
| Human granzyme B regulatory B cells prevent effector CD4+CD25- T cell proliferation through a mechanism dependent from lymphotoxin alpha. | Front Immunol | 2023 | 37588598 | PubTator, text mining | PubMed |
| Receptor-mediated drug delivery of bispecific therapeutic antibodies through the blood-brain barrier. | Front Drug Deliv | 2023 | 37583474 | PubTator, text mining | PubMed |
| The roles of phospholipase C-β related signals in the proliferation, metastasis and angiogenesis of malignant tumors, and the corresponding protective measures. | Front Oncol | 2023 | 37576896 | PubTator, text mining | PubMed |
Unveiling efferocytosis-related signatures through the integration of single-cell analysis and machine learning: a predictive framework for prognosis and immunotherapy response in hepatocellular carcinoma. | Front Immunol | 2023 | 37575252 | PubTator, text mining | PubMed |
| The extracellular vesicles targeting tumor microenvironment: a promising therapeutic strategy for melanoma. | Front Immunol | 2023 | 37575250 | PubTator, text mining | PubMed |
| Comparative Molecular Characterization and Pharmacokinetics of IgG1-Fc and Engineered Fc Human Antibody Variants to Insulin-like Growth Factor 2 Receptor (IGF2R). | Molecules | 2023 | 37570809 | PubTator, text mining | PubMed |
| Whole-Exome and Transcriptome Sequencing Expands the Genotype of Majewski Osteodysplastic Primordial Dwarfism Type II. | Int J Mol Sci | 2023 | 37569667 | PubTator, text mining | PubMed |
| Radiotherapy in bone sarcoma: the quest for better treatment option. | BMC Cancer | 2023 | 37563551 | PubTator, text mining | PubMed |
| Altered endosomal-lysosomal biogenesis in melanoma. | Neoplasia | 2023 | 37562257 | PubTator, text mining | PubMed |
| Harnessing the Lysosomal Sorting Signals of the Cation-Independent Mannose-6-Phosphate Receptor for Targeted Degradation of Membrane Proteins. | J Am Chem Soc | 2023 | 37552887 | PubTator, text mining | PubMed |
| Heparanase-A single protein with multiple enzymatic and nonenzymatic functions. | Proteoglycan Res | 2023 | 37547889 | PubTator, text mining | PubMed |
| eIF3f Mediates SGOC Pathway Reprogramming by Enhancing Deubiquitinating Activity in Colorectal Cancer. | Adv Sci (Weinh) | 2023 | 37544925 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3482/papers?page=16